Chronic Kidney Disease

The AJMC® Chronic Kidney Disease compendium is a comprehensive resource for clinical news and expert insights on the condition and treatment of loss of kidney function.

Combination Therapy and Payer Perspective on CKD Therapies

September 28th 2022, 3:35pm


Dr Bertram Pitt explains the possibility of combining SGLT2 inhibitors and MRAs when treating CKD and CV, and Paul Sapia, MHA, discusses how payers balance cost of care with disease progression and health disparities.

Using Published Data to Consider SGLT2 Inhibitors and MRAs in CKD Management

September 28th 2022, 3:16pm


Dr Jeffrey Feldman discusses finerenone trial data and the role that it and SGLT2 inhibitors have played in patients with CKD.

Kidney Transplant Recipients Able to Find Stable Work Post Surgery

September 26th 2022, 9:00pm


A recent report found that 56% of patients from The Netherlands who underwent a kidney transplant were able to work and functioned well while working.

Genomic Testing Could Be More Beneficial for Patients With CKD

September 24th 2022, 12:29pm


Genomic testing can benefit patients with chronic kidney disease (CKD) as more causative genes are identified and evidence for clinical utility is discovered.

The Role of MRAs in CKD and CV Treatment

September 21st 2022, 2:13pm


Dr Agarwal provides a deep dive into the use of nonsteroidal mineralocorticoid receptor antagonists in CKD therapy.

Treating CKD Using Multiple Methods

September 21st 2022, 2:02pm


Dr Feldman concludes the treatment landscape overview by discussing glycemic control, SGLT2 inhibitors, and other important management techniques.

Use of Anticoagulants Has Increased for Patients With Atrial Fibrillation, CKD

September 19th 2022, 5:56pm


A recent study found that patients with chronic kidney disease and atrial fibrillation are increasingly using direct oral anticoagulants.

Improved Air Pollution Levels Linked With Less Renal Function Decline During COVID-19 Pandemic

September 13th 2022, 4:23pm


A retrospective cohort study found that a drop in events signaling renal function decline during the COVID-19 pandemic could be associated with a decrease in fine particulate matter concentration.

Milken Institute's Sarah Wells Kocsis Talks About CKD Care Moving Forward

September 8th 2022, 4:25pm


Sarah Wells Kocsis, MBA, coauthor of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management,” discusses how the health care system can better suit the needs of patients with chronic kidney disease (CKD).

Low Handgrip Strength, Obesity Associated With Increased Risk of CKD in Women

September 6th 2022, 6:20pm


Post-menopausal women who had dynapenic-abdominal obesity, determined by hand-grip strength and waist circumference, had a higher risk of chronic kidney disease (CKD) compared with controls.